FPR2 Agonists and Antagonists Research: the global market size is projected to reach USD 0.29 billion by 2032

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "FPR2 Agonists and Antagonists- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global FPR2 Agonists and Antagonists market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for FPR2 Agonists and Antagonists was estimated to be worth US$ 126 million in 2025 and is projected to reach US$ 356 million, growing at a CAGR of 16.4% from 2026 to 2032.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5902446/fpr2-agonists-and-antagonists

Product Overview and Scope of FPR2 Agonists and Antagonists

FPR2 agonists: These are molecules that bind to N-formyl peptide receptor 2 (FPR2/ALX) and activate the receptor conformation and downstream signal transduction (manifesting as complete agonism, partial agonism, or "biased agonism"). A common characteristic of the FPR2 system is that ligands can induce different signal biases and biological effects (e.g., pro-inflammatory or pro-inflammatory resolution/repair), therefore, research and development often further subdivides them according to "bias."

FPR2 antagonists: These are molecules that bind to FPR2 and block agonist-induced receptor activation (typically manifested as inhibition of Ca2+ mobilization, chemotaxis, and other readouts), used in tool research or potential therapeutic strategies to "inhibit certain FPR2-mediated pathological responses." Some commonly used antagonist peptides (e.g., WRW4) are frequently used to verify the specificity of FPR2-related effects.

From a raw material perspective, FPR2 agonists/antagonists most commonly fall into two categories in research and development and supply applications: peptides and small molecule/lipid peptides. Peptides (many of which are agonist/antagonist peptides) are typically synthesized using solid-phase peptide synthesis (SPPS): the main raw materials are amino acid monomers, resin carriers, coupling/deprotection reagents, and large amounts of organic solvents, and they are highly dependent on HPLC purification and mass spectrometry analysis for release. Therefore, the cost structure often shows a high proportion of purification and detection costs; the longer the sequence, the more hydrophobic, or the more likely it is to form byproducts, the higher the unit cost. Upgrading from research-grade to GMP-grade significantly increases costs due to additional documentation, validation, and more stringent testing.

For FPR2 agonist routes involving lipid mediators/lipoxygen-like molecules (or their mimics), the raw materials often come from chiral/unsaturated fragments, protecting reagents, and solvents required for multi-step organic synthesis. This makes the cost more easily amplified by factors such as chemical instability, isomer control, low-temperature and light-protected storage and transportation, and complex purification. This is why many R&D efforts shift towards more stable mimics/small molecule agonists with better physicochemical properties to improve manufacturability and cost control.

Overall conclusion: Under the same purity and traceability requirements, short peptides have relatively more predictable costs but are expensive to purify and detect; lipids/complex small molecules are more affected by synthesis difficulty and stability/storage and transportation, resulting in greater fluctuations in unit cost.

FPR2 Agonists and Antagonists Market Summary

According to the new market research report "Global FPR2 Agonists and Antagonists Market Report 2026-2032", published by QYResearch, the global FPR2 Agonists and Antagonists market size is projected to reach USD 0.29 billion by 2032, at a CAGR of 15.6% during the forecast period.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The FPR2 Agonists and Antagonists market is segmented as below:
By Company
Bio-Techne
Abcam
Enzo Life Sciences
MedChemExpress
Anaspec
Merck
Discoverx
BioGems
GenScript Company
Alomone Labs

Segment by Type
Agonists
Antagonists

Segment by Application
Pharmaceutical Company
Universities and Research Institutes
Others

Each chapter of the report provides detailed information for readers to further understand the FPR2 Agonists and Antagonists market:

Chapter 1: Introduces the report scope of the FPR2 Agonists and Antagonists report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of FPR2 Agonists and Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various FPR2 Agonists and Antagonists market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of FPR2 Agonists and Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of FPR2 Agonists and Antagonists in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth FPR2 Agonists and Antagonists competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides FPR2 Agonists and Antagonists comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides FPR2 Agonists and Antagonists market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global FPR2 Agonists and Antagonists Market Research Report 2026
Global FPR2 Agonists and Antagonists Market Outlook, In‐Depth Analysis & Forecast to 2032
Global FPR2 Agonists and Antagonists Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.